Propiedad y actividad de insiders de Kiora Pharmaceuticals, Inc. (KPRX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $2.60 |
| Capitalización | $12M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $3.6M | $7.8M | $8.0M | $3.8M | $1.2M | $7.9M | $6.0M | $2.5M | $3.8M | $8.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $23.0M | $8.4M |
| Cuentas por Cobrar | $53833 | $23685 | $18436 | $4857 | $90975 | $529560 | $1.4M | $2.0M | $601197 | $3.3M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $4.2M | $8.5M | $8.5M | $4.3M | $1.7M | $9.0M | $7.7M | $4.7M | $29.7M | $21.7M |
| Inmovilizado Material | $38040 | $55751 | $43518 | $16846 | $114494 | $283410 | $172169 | $114954 | $62402 | $377499 |
| Fondo de Comercio | $5.4M | 0 | $1.5M | $1.5M | $3.6M | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $5.4M | $4.2M | $4.1M | $9.7M | $10.8M | $10.7M | $8.8M | $6.7M | $2.1M |
| Activos Totales | $9.7M | $14.3M | $14.3M | $10.1M | $15.3M | $20.1M | $18.7M | $13.7M | $36.5M | $24.3M |
| Cuentas por Pagar | $1.4M | $706089 | $63654 | $210289 | $434763 | $160621 | $1.0M | $206260 | $415590 | $1.1M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $212281 | 0 | 0 | $47069 | 0 | $164461 |
| Pasivos Corrientes | $7.3M | $14.8M | $3.9M | $1.4M | $2.0M | $1.6M | $3.3M | $1.6M | $6.0M | $3.6M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $278190 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $10.1M | $16.2M | $5.3M | $3.5M | $5.6M | $5.6M | $7.3M | $7.6M | $10.7M | $8.1M |
| Reservas | -$78.6M | -$91.8M | -$93.2M | -$100.2M | -$107.1M | -$120.9M | -$134.5M | -$147.0M | -$143.4M | -$154.2M |
| Patrimonio Neto | -$329421 | -$1.9M | $8.9M | $6.6M | $9.7M | $14.6M | $11.4M | $6.1M | $25.8M | $16.1M |
| Deuda Total | $28714 | $16069 | $4715 | $83926 | $574399 | $209412 | $105782 | $106891 | $57170 | $368259 |
| Deuda Neta | -$3.6M | -$7.8M | -$8.0M | -$3.7M | -$611278 | -$7.6M | -$5.9M | -$2.3M | -$26.7M | -$16.7M |
| Capital Circulante | -$3.2M | -$6.4M | $4.6M | $2.9M | -$258387 | $7.4M | $4.4M | $3.1M | $23.7M | $18.1M |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 8.97 |
Rentabilidad
| Rentabilidad sobre capital | -63.39% |
| Rentabilidad sobre capital invertido | -53.16% |
| Rentabilidad sobre activos | -46.21% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ACXP · ADIL · APRE · APVO · BCDA · CELZ · HCWB
Explorar sector: Healthcare · Biotechnology
Más secciones de KPRX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones